The Mediating Role of Death Anxiety in Hemodialysis Patients
NCT ID: NCT06478446
Last Updated: 2024-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
203 participants
OBSERVATIONAL
2023-10-02
2024-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Education Given to Patients With Hemodialysis Patients
NCT06534476
The Effect of the Care Given to Hemodialysis Patients on Comfort Level and Complaints
NCT06274099
The Effect of Stress Ball Use on Comfort, Anxiety, and Patient Satisfaction in Hemodialysis Patients
NCT06977867
Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation
NCT06382701
The Effect of Patient Education Based on Nursing Model on Life Activities and Self-Care of Hemodialysis Patients
NCT04797234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sample The data of Burucu and Cantekin (2022) were used to determine the sample size. In this study, it was reported that death anxiety in dialysis patients varied according to the type of dialysis. In the mentioned study, R2 was 0.062. According to the multiple regression results on death anxiety, it was determined that the study should be completed with at least 149 participants to achieve 80% power and an effect size of 0.066. According to Dunson and Bollen, Structural Equation Modeling can be adequately performed with small sample sizes (approximately 100). However, it is recommended that the sample size should be 200 or more. Therefore, the calculated number was increased by 35% in line with the literature and the sample size of the study was determined as 201. A total of 203 patients were included in the study.
Data Collection Tools Descriptive Characteristics Form, Religious Attitude Scale (RAS), Spiritual Care Needs Scale (SCNS), and Death Anxiety Scale (DAS) were used for data collection.
Data were collected face-to-face by the researchers in the hemodialysis (HD) unit. During data collection, protective measures were taken to prevent the risk of infection. The patients were informed about the study and their consent was obtained.
Ethical approval was obtained from the XXX University Health Sciences Scientific Research Ethics Committee, and necessary permissions were obtained from XXX University Medical Faculty Hospital. All stages of the study were completed in accordance with the STROBE checklist and the Declaration of Helsinki.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation
HD patients were observed and evaluated with three scales.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being a resident in Turkey
* To be continuing HD treatment
* Not having communication barriers
Exclusion Criteria
* Those who are in the last stage of the disease,
* Those undergoing cancer treatment
* Those with cognitive impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Necmettin Erbakan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rukiye Burucu
Associate prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NECMETTİN EU-
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.